Vegetarian diet associated with decreased risk of colorectal cancer
the ONA take:
According to a recent article published in JAMA Internal Medicine, consuming a vegetarian diet was linked with a decreased risk for developing colorectal cancers compared with eating a nonvegetarian diet.
For the study, researchers analyzed data from 77,659 men and women and identified 380 colon cancer cases and 110 rectal cancer cases.
Results showed that vegetarians had a 22% decreased risk for all colorectal cancers, 19% decreased risk for colon cancer, and 29% decreased risk for rectal cancer compared with nonvegetarians.
In addition, vegans had a 16% decreased risk for colorectal cancer compared with nonvegetarians and lacto-ovo vegetarians had a 18% lower risk than nonvegetarians. Pescovegetarians had a 43% lower risk for colorectal cancers compared with nonvegetarians.
The authors conclude that "the evidence that vegetarian diets similar to those of our study participants may be associated with a reduced risk of colorectal cancer, along with prior evidence of the potential reduced risk of obesity, hypertension, diabetes and mortality, should be considered carefully in making dietary choices and in giving dietary guidance."
Red meat has already been linked to an increased risk for colorectal cancer while a diet rich in fiber has been associated with a reduced risk.
Consuming a vegetarian diet was linked with a decreased risk for developing colorectal cancers.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|